Evoke Pharma (NASDAQ:EVOK) Share Price Passes Below 200 Day Moving Average of $0.66

Evoke Pharma, Inc. (NASDAQ:EVOK) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.66 and traded as low as $0.50. Evoke Pharma shares last traded at $0.53, with a volume of 10,952 shares.

Analysts Set New Price Targets

Separately, StockNews.com initiated coverage on shares of Evoke Pharma in a report on Saturday. They set a “sell” rating for the company.

Evoke Pharma Stock Up 5.5 %

The firm has a market cap of $4.55 million, a price-to-earnings ratio of -0.29 and a beta of 0.36. The business’s fifty day moving average is $0.49 and its two-hundred day moving average is $0.66.

Evoke Pharma (NASDAQ:EVOK) last issued its quarterly earnings results on Tuesday, May 14th. The specialty pharmaceutical company reported ($0.17) earnings per share for the quarter. The company had revenue of $1.74 million during the quarter. Evoke Pharma had a negative net margin of 116.75% and a negative return on equity of 4,908.09%.

Evoke Pharma Company Profile

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.